A safety analysis conducted by the FDA and the CDC links Merck & Co.'s cervical cancer vaccine Gardasil to 1,900 reports of fainting and 56 incidents of blood clots. Also, a medical article written by Columbia University researchers criticizes Merck's marketing strategy for the drug, saying it failed to address "the full complexity of the issues surrounding the vaccine and did not provide balanced recommendations on risks and benefits."

Related Summaries